Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 123

1.

Extracellular matrix composition is modified by β₂-agonists through cAMP in COPD.

Lambers C, Qi Y, Eleni P, Costa L, Zhong J, Tamm M, Block LH, Roth M.

Biochem Pharmacol. 2014 Oct 1;91(3):400-8. doi: 10.1016/j.bcp.2014.07.026. Epub 2014 Aug 12.

PMID:
25107701
2.

Inter-grade and inter-batch variability of sodium alginate used in alginate-based matrix tablets.

Fu S, Buckner IS, Block LH.

AAPS PharmSciTech. 2014 Oct;15(5):1228-37. doi: 10.1208/s12249-014-0154-3. Epub 2014 Jun 3.

3.

Autonomic Reactivity to Infant Crying in Maltreating Mothers.

Reijman S, Alink LR, Block LH, Werner CD, Maras A, Rijnberk C, IJzendoorn MH, Bakermans-Kranenburg MJ.

Child Maltreat. 2014 May;19(2):101-112. Epub 2014 May 29.

PMID:
24879060
4.

The interaction of endothelin-1 and TGF-β1 mediates vascular cell remodeling.

Lambers C, Roth M, Zhong J, Campregher C, Binder P, Burian B, Petkov V, Block LH.

PLoS One. 2013 Aug 28;8(8):e73399. doi: 10.1371/journal.pone.0073399. eCollection 2013.

5.

Analysis of composition, molecular weight, and water content variations in sodium alginate using solid-state NMR spectroscopy.

Sperger DM, Fu S, Block LH, Munson EJ.

J Pharm Sci. 2011 Aug;100(8):3441-3452. doi: 10.1002/jps.22559. Epub 2011 Mar 31.

PMID:
21455981
6.

Relevance of rheological properties of sodium alginate in solution to calcium alginate gel properties.

Fu S, Thacker A, Sperger DM, Boni RL, Buckner IS, Velankar S, Munson EJ, Block LH.

AAPS PharmSciTech. 2011 Jun;12(2):453-60. doi: 10.1208/s12249-011-9587-0. Epub 2011 Mar 25.

7.

Rheological evaluation of inter-grade and inter-batch variability of sodium alginate.

Fu S, Thacker A, Sperger DM, Boni RL, Velankar S, Munson EJ, Block LH.

AAPS PharmSciTech. 2010 Dec;11(4):1662-74. doi: 10.1208/s12249-010-9547-0. Epub 2010 Nov 24. Erratum in: AAPS PharmSciTech. 2011 Mar;12(1):449.

8.

Inter- and intra-manufacturer variability in pharmaceutical grades and lots of xanthan gum.

Thacker A, Fu S, Boni RL, Block LH.

AAPS PharmSciTech. 2010 Dec;11(4):1619-26. doi: 10.1208/s12249-010-9536-3. Epub 2010 Nov 18.

9.

Unusual microbes in asthma exacerbation: Alcaligenes xylosoxidans and Leishmania.

Robibaro B, Funk GC, Dekan G, Demetriou D, Ziesche R, Winkler S, Block LH.

Eur Respir J. 2009 May;33(5):1216-9. doi: 10.1183/09031936.00123708.

10.

The calcium channel blocker amlodipine exerts its anti-proliferative action via p21(Waf1/Cip1) gene activation.

Ziesche R, Petkov V, Lambers C, Erne P, Block LH.

FASEB J. 2004 Oct;18(13):1516-23.

PMID:
15466360
11.

[Austrian Society for Pulmonary Diseases and Tuberculosis. Consensus concerning the management of chronic obstructive pulmonary diseases (COPD). Revised draft 2004].

Block LH, Burghuber OC, Hartl S, Zwick H; Osterreichische Gesellschaft für Lungenerkrankungen und Tuberkulose.

Wien Klin Wochenschr. 2004 Apr 30;116(7-8):268-78. German. No abstract available.

PMID:
15143868
12.

Hyperglycemia, bronchial artery sclerosis, and lung function.

Funk GC, Doberer D, Petkov V, Block LH.

Am J Respir Crit Care Med. 2004 Feb 1;169(3):427; author reply 427. No abstract available.

PMID:
14739135
13.

Vasoactive intestinal peptide as a new drug for treatment of primary pulmonary hypertension.

Petkov V, Mosgoeller W, Ziesche R, Raderer M, Stiebellehner L, Vonbank K, Funk GC, Hamilton G, Novotny C, Burian B, Block LH.

J Clin Invest. 2003 May;111(9):1339-46.

14.

Long-term treatment with oral sildenafil in addition to continuous IV epoprostenol in patients with pulmonary arterial hypertension.

Stiebellehner L, Petkov V, Vonbank K, Funk G, Schenk P, Ziesche R, Block LH.

Chest. 2003 Apr;123(4):1293-5.

PMID:
12684325
15.

Controlled prospective randomised trial on the effects on pulmonary haemodynamics of the ambulatory long term use of nitric oxide and oxygen in patients with severe COPD.

Vonbank K, Ziesche R, Higenbottam TW, Stiebellehner L, Petkov V, Schenk P, Germann P, Block LH.

Thorax. 2003 Apr;58(4):289-93.

16.

Spray-dried chitinosans. Part II: in vitro drug release from tablets made from spray-dried chitinosans.

Rege PR, Garmise RJ, Block LH.

Int J Pharm. 2003 Feb 18;252(1-2):53-9.

PMID:
12550780
17.

Spray-dried chitinosans. Part I: preparation and characterization.

Rege PR, Garmise RJ, Block LH.

Int J Pharm. 2003 Feb 18;252(1-2):41-51.

PMID:
12550779
18.

Chitinosan-drug complexes: effect of electrolyte on naproxen release in vitro.

Rege PR, Shukla DJ, Block LH.

Int J Pharm. 2003 Jan 2;250(1):259-72.

PMID:
12480291
19.

Solubility, ionization, and partitioning behavior of unsymmetrical disulfide compounds: alkyl 2-imidazolyl disulfides.

Hashash A, Kirkpatrick DL, Lazo JS, Block LH.

J Pharm Sci. 2002 Jul;91(7):1686-92.

PMID:
12115830
20.

Normal-phase and stability-indicating reversed-phase high-performance liquid chromatographic methods for the determination of the novel antitumor agent: 1-methylpropyl-2-imidazolyldisulfide.

Hashash A, Kirkpatrick DL, Egorin MJ, Block LH, Lazo JS.

J Chromatogr B Analyt Technol Biomed Life Sci. 2002 Mar 5;768(2):239-46.

PMID:
11888051
21.

Interaction of C/EBPalpha and the glucocorticoid receptor in vivo and in nontransformed human cells.

Rüdiger JJ, Roth M, Bihl MP, Cornelius BC, Johnson M, Ziesche R, Block LH.

FASEB J. 2002 Feb;16(2):177-84.

PMID:
11818365
22.

Aerosolised iloprost improves pulmonary haemodynamics in patients with primary pulmonary hypertension receiving continuous epoprostenol treatment.

Petkov V, Ziesche R, Mosgoeller W, Schenk P, Vonbank K, Stiebellehner L, Raderer M, Brunner C, Kneussl M, Block LH.

Thorax. 2001 Sep;56(9):734-6.

23.
24.

The use of chitosan gels as matrices for electrically-modulated drug delivery.

Ramanathan S, Block LH.

J Control Release. 2001 Jan 29;70(1-2):109-23.

PMID:
11166412
25.

APhA, the Journal of Pharmaceutical Sciences, and the future of the profession.

Block LH.

J Am Pharm Assoc (Wash). 2000 Nov-Dec;40(6):715-6. No abstract available.

PMID:
11111350
26.

[New therapeutic approaches in pulmonary fibrosis].

Ziesche R, Block LH.

Pneumologie. 2000 Oct;54(10):431-3. Review. German. No abstract available.

PMID:
11089394
27.

Mechanisms of antifibrotic action of interferon gamma-1b in pulmonary fibrosis.

Ziesche R, Block LH.

Wien Klin Wochenschr. 2000 Sep 29;112(18):785-90. Review.

PMID:
11072666
28.
29.

Chitosan as an enabling excipient for drug delivery systems. I. Molecular modifications.

Sabnis S, Block LH.

Int J Biol Macromol. 2000 Jun 13;27(3):181-6.

PMID:
10828363
30.

Effects of trovafloxacin on the IL-1-dependent activation of E-selectin in human endothelial cells in vitro.

Zakeri SM, Meyer H, Meinhardt G, Reinisch W, Schrattbauer K, Knoefler M, Block LH.

Immunopharmacology. 2000 Jun;48(1):27-34.

PMID:
10822086
31.

Treatment with epoprostenol reverts nitric oxide non-responsiveness in patients with primary pulmonary hypertension.

Ziesche R, Petkov V, Wittmann K, Kopatschka J, Stiebellehner L, Schenk P, Germann P, Röder G, Ullrich R, Block LH.

Heart. 2000 Apr;83(4):406-9.

32.

[Austrian Society for Lung Diseases and Tuberculosis: Consensus on diagnosis and therapy of bronchial asthma in adults. Revised draft 1999].

Aigner K, Block LH, Kneussl M, Kummer F, Neumann M, Zach M, Zwick H.

Wien Klin Wochenschr. 1999 Dec 23;111(24):1044-7. Review. German. No abstract available.

PMID:
10677892
33.

Facile synthesis of a chitosan hybrid of a laminin-related peptide and its antimetastatic effect in mice.

Hojo K, Maeda M, Mu Y, Kamada H, Tsutsumi Y, Nishiyama Y, Yoshikawa T, Kurita K, Block LH, Mayumi T, Kawasaki K.

J Pharm Pharmacol. 2000 Jan;52(1):67-73.

PMID:
10716605
34.

Lyophilization of cationic lipid-protamine-DNA (LPD) complexes.

Li B, Li S, Tan Y, Stolz DB, Watkins SC, Block LH, Huang L.

J Pharm Sci. 2000 Mar;89(3):355-64.

PMID:
10707016
35.

[Austrian Society of Lung Diseases and Tuberculosis: Consensus on Management of Chronic Obstructive Lung Diseases (COPD). 1999 Revision].

Aigner K, Block LH, Kneussl M, Kummer F, Neumann M, Zach M, Zwick H.

Wien Klin Wochenschr. 2000 Jan 14;112(1):41-5. Review. German. No abstract available.

PMID:
10689740
36.

A preliminary study of long-term treatment with interferon gamma-1b and low-dose prednisolone in patients with idiopathic pulmonary fibrosis.

Ziesche R, Hofbauer E, Wittmann K, Petkov V, Block LH.

N Engl J Med. 1999 Oct 21;341(17):1264-9. Erratum in: N Engl J Med 2000 Feb 17;342(7):524.

37.
38.

Chitinosans as tableting excipients for modified release delivery systems.

Rege PR, Shukla DJ, Block LH.

Int J Pharm. 1999 Apr 20;181(1):49-60.

PMID:
10370202
39.

Calcium channel blockers activate the interleukin-6 gene via the transcription factors NF-IL6 and NF-kappaB in primary human vascular smooth muscle cells.

Eickelberg O, Roth M, Mussmann R, Rüdiger JJ, Tamm M, Perruchoud AP, Block LH.

Circulation. 1999 May 4;99(17):2276-82.

PMID:
10226093
40.

[The lung as an immunologic organ].

Ziesche R, Block LH.

Wien Klin Wochenschr. 1999;111 Suppl 1:1-5. Review. German.

PMID:
10194844
41.
42.

The differential distribution of hyaluronic acid in the layers of human atheromatic aortas is associated with vascular smooth muscle cell proliferation and migration.

Papakonstantinou E, Roth M, Block LH, Mirtsou-Fidani V, Argiriadis P, Karakiulakis G.

Atherosclerosis. 1998 May;138(1):79-89.

PMID:
9678773
43.

A 340 kDa hyaluronic acid secreted by human vascular smooth muscle cells regulates their proliferation and migration.

Papakonstantinou E, Karakiulakis G, Eickelberg O, Perruchoud AP, Block LH, Roth M.

Glycobiology. 1998 Aug;8(8):821-30.

PMID:
9639543
45.
46.
47.

Lipopolysaccharide and interleukin 1 augment the effects of hypoxia and inflammation in human pulmonary arterial tissue.

Ziesche R, Petkov V, Williams J, Zakeri SM, Mosgöller W, Knöfler M, Block LH.

Proc Natl Acad Sci U S A. 1996 Oct 29;93(22):12478-83.

48.

Ca2+ channel blockers modulate metabolism of collagens within the extracellular matrix.

Roth M, Eickelberg O, Kohler E, Erne P, Block LH.

Proc Natl Acad Sci U S A. 1996 May 28;93(11):5478-82.

49.

[Cell proliferation factors and vascular damage].

Block LH, Roth M.

Cardiologia. 1996 May;41 Suppl 1:13-7. Italian. No abstract available.

PMID:
8831176
50.

Induction of interleukin 6 and interleukin 8 expression by Broncho-Vaxom (OM-85 BV) via C-Fos/serum responsive element.

Keul R, Roth M, Papakonstantinou E, Nauck M, Perruchoud AP, Block LH.

Thorax. 1996 Feb;51(2):150-4.

Supplemental Content

Loading ...
Support Center